INTRACEREBRAL HAEMORRHAGE:

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective Cathy Sila MD George M Humphrey II Professor and Vice Chair of Neurology Director, Comprehensive Stroke Center

Restart or stop antithrombotics after intracerebral haemorrhage (ICH)?

Restart or stop antithrombotics after intracerebral haemorrhage (ICH)? Rustam Al-Shahi Salman professor of clinical neurology & honorary consultant neurologist www.rush.ed.ac.uk @BleedingStroke /bleedingstroke

A common clinical dilemma. Ischaemic stroke or TIA with atrial fibrillation MRI scan with blood-sensitive imaging shows cerebral microbleeds

Cerebral microbleeds and intracranial haemorrhage risk in patients with atrial fibrillation after acute ischaemic stroke or transient ischaemic attack: multicentre observational cohort study D. Wilson,

Classification of Intracerebral Haemorrhages

Classification of Intracerebral Haemorrhages Renan Domingues, 1,4 Costanza Rossi 2 and Charlotte Cordonnier 3 1. Neurologist and Professor; 2. Neurologist; 3. Neurologist and Professor, Department of Neurology,

Intracranial spontaneous hemorrhage mechanisms, imaging and management

Intracranial spontaneous hemorrhage mechanisms, imaging and management Dora Zlatareva Department of Diagnostic Imaging Medical University, Sofia, Bulgaria Intracranial hemorrhage (ICH) ICH 15% of strokes

Hypertensive Haemorrhagic Stroke. Dr Philip Lam Thuon Mine

Hypertensive Haemorrhagic Stroke Dr Philip Lam Thuon Mine Intracerebral Haemorrhage Primary ICH Spontaneous rupture of small vessels damaged by HBP Basal ganglia, thalamus, pons and cerebellum Amyloid

New Frontiers in Intracerebral Hemorrhage

New Frontiers in Intracerebral Hemorrhage Ryan Hakimi, DO, MS Director, Neuro ICU Director, Inpatient Neurology Services Greenville Health System Clinical Associate Professor Department of Medicine (Neurology)

Patients presenting with acute stroke while on DOACs

Patients presenting with acute stroke while on DOACs Vemmos Kostas, MD, PhD Stroke Medicine Hellenic Cardiovascular Research Society Conflicts of interest Honoraria and speaker fees from: BAYER, SANOFI,

M. Edip Gurol, MD, MSc Stroke Service/Neurology, Massachusetts General Hospital, Harvard Medical School

High Risk of Thromboembolism and ICH: Problems with Medical Management M. Edip Gurol, MD, MSc Stroke Service/Neurology, Massachusetts General Hospital, Harvard Medical School Disclosures Funding from NIH

Giuseppe Micieli Dipartimento di Neurologia d Urgenza IRCCS Fondazione Istituto Neurologico Nazionale C Mondino, Pavia

Giuseppe Micieli Dipartimento di Neurologia d Urgenza IRCCS Fondazione Istituto Neurologico Nazionale C Mondino, Pavia Charidimou et al, 2012 Pathogenesis of spontaneous and anticoagulationassociated

Modern Management of ICH

Modern Management of ICH Bradley A. Gross, MD Assistant Professor, Dept of Neurosurgery, University of Pittsburgh October 2018 ICH Background Assessment & Diagnosis Medical Management Surgical Management

NEURORADIOLOGY Part I

NEURORADIOLOGY Part I Vörös Erika University of Szeged Department of Radiology SZEGED BRAIN IMAGING METHODS Plain film radiography Ultrasonography (US) Computer tomography (CT) Magnetic resonance imaging

Distinguishing clinical and radiological features of non-traumatic convexal subarachnoid hemorrhage

ORIGINAL ARTICLE Distinguishing clinical and radiological features of non-traumatic convexal subarachnoid hemorrhage J. Graff-Radford, J. E. Fugate, J. Klaas, K. D. Flemming, R. D. Brown and A. A. Rabinstein

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

Stroke & the Emergency Department Dr. Barry Moynihan, March 2 nd, 2012 Outline Primer Stroke anatomy & clinical syndromes Diagnosing stroke Anterior / Posterior Thrombolysis Haemorrhage The London model

UPSTATE Comprehensive Stroke Center. Neurosurgical Interventions Satish Krishnamurthy MD, MCh

UPSTATE Comprehensive Stroke Center Neurosurgical Interventions Satish Krishnamurthy MD, MCh Regional cerebral blood flow is important Some essential facts Neurons are obligatory glucose users Under anerobic

doi: /brain/awq246 Brain 2010: 133; What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?

doi:10.1093/brain/awq246 Brain 2010: 133; 3281 3289 3281 BRAIN A JOURNAL OF NEUROLOGY What are the causes of pre-existing dementia in patients with intracerebral haemorrhages? Charlotte Cordonnier, 1 Didier

Acute Stroke Management Conference 2019: Stroke Clinical Vignettes

Acute Stroke Management Conference 2019: Stroke Clinical Vignettes Cynthia Kenmuir MD PhD Director of Stroke Program, UPMC Altoona Director of Neurointerventional Program, UPMC Altoona 2015 Guideline for

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece Disclosures Scholarships: European Stroke Organization; Hellenic Society of Atherosclerosis.

Angel J. Lacerda MD PhD, Daisy Abreu MD, Julio A. Díaz MD, Sandro Perez MD, Julio C Martin MD, Daiyan Martin MD.

Angel J. Lacerda MD PhD, Daisy Abreu MD, Julio A. Díaz MD, Sandro Perez MD, Julio C Martin MD, Daiyan Martin MD. Introduction: Spontaneous intracerebral haemorrhage (SICH) represents one of the most severe

Controversies in Hemorrhagic Stroke Management. Sarah L. Livesay, DNP, RN, ACNP-BC, ACNS-BC Associate Professor Rush University

Controversies in Hemorrhagic Stroke Management Sarah L. Livesay, DNP, RN, ACNP-BC, ACNS-BC Associate Professor Rush University Disclosures AHA/ASA Outline Blood pressure VTE Coagulopathy Early mobilization

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging REBECCA F. GOTTESMAN, MD PHD ASSOCIATE PROFESSOR OF NEUROLOGY AND EPIDEMIOLOGY JOHNS HOPKINS UNIVERSITY OCTOBER 20, 2014 Outline

Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy

Paterson, Abdi 1 Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy Ross W Paterson MRCP 1 *, Zeinab Abdi MRCP 1 *, Amanda Haines RMN 1, Jonathan M

In patients with spontaneous intracerebral hemorrhage

Incident Cerebral Microbleeds in a Cohort of Intracerebral Hemorrhage Marta Pasquini, MD; Marije R. Benedictus, MSc; Grégoire Boulouis, MD; Costanza Rossi, PhD; Nelly Dequatre-Ponchelle, MD; Charlotte

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase

Acute stroke imaging

Acute stroke imaging Aims Imaging modalities and differences Why image acute stroke Clinical correlation to imaging appearance What is stroke Classic definition: acute focal injury to the central nervous

Cerebral small vessel disease

Cerebral small vessel disease What is it? What are the clinical syndromes? How do we diagnose it? What is the pathophysiology? New insights from genetics? Possible therapies? Small Vessel disease Changes

Diagnosis of Subarachnoid Hemorrhage (SAH) and Non- Aneurysmal Causes

Diagnosis of Subarachnoid Hemorrhage (SAH) and Non- Aneurysmal Causes By Sheila Smith, MD Swedish Medical Center 1 Disclosures I have no disclosures 2 Course Objectives Review significance and differential

Recombinant Factor VIIa for Intracerebral Hemorrhage

Recombinant Factor VIIa for Intracerebral Hemorrhage January 24, 2006 Justin Lee Pharmacy Resident University Health Network Outline 1. Introduction to patient case 2. Overview of intracerebral hemorrhage

Lothian Audit of the Treatment of Cerebral Haemorrhage (LATCH)

1. INTRODUCTION Stroke physicians, emergency department doctors, and neurologists are often unsure about which patients they should refer for neurosurgical intervention. Early neurosurgical evacuation

A report of nontraumatic cortical subarachnoid hemorrhage and subsequent management

For reprint orders, please contact: reprints@futuremedicine.com A report of nontraumatic cortical subarachnoid hemorrhage and subsequent management David Qiyuan Mao*,1, Daniel Addess 1 & Helen Valsamis

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

Neuroanatomy of a Stroke Joni Clark, MD Professor of Neurology Barrow Neurologic Institute No disclosures Stroke case presentations Review signs and symptoms Review pertinent exam findings Identify the

Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum

Cerebrovascular disease Stroke Research Group, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and the National Hospital for Neurology and Neurosurgery, Queen Square, London,

Luisa Vinciguerra. Ictus recidivanti

Luisa Vinciguerra Ictus recidivanti Recurrent Strokes DEFINITION Population-based studies exclude strokes: - within 28 or 21 days of the incident event - events in the same vascular territory as the original

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville Disclosure Statement of Financial Interest Within the

Cerebral microbleeds (CMBs) are detected on T2*-

Cerebral Microbleeds and Recurrent Stroke Risk Systematic Review and Meta-Analysis of Prospective Ischemic Stroke and Transient Ischemic Attack Cohorts Andreas Charidimou, MSc; Puneet Kakar, MD; Zoe Fox,

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor

When Not To Give TPA Steve Phillips Division of Neurology

When Not To Give TPA Steve Phillips Division of Neurology stephen.phillips@nshealth.ca AstraZeneca Disclosures - 1 I have given CME lectures and served on advisory boards for Boehringer Ingelheim Bristol-Myers

Brain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage

Cronicon OPEN ACCESS EC PAEDIATRICS Case Report Brain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage Dimitrios Panagopoulos* Neurosurgical Department, University

Updates from 2017 International Stroke Conferences

Updates from 2017 International Stroke Conferences Ravi Menon, MD Swedish Neuroscience Institute May 11, 2017 Seattle, WA 1 Disclosures No relevant financial disclosures Clinical trial involvement: Former

www.yassermetwally.com MANAGEMENT OF CEREBRAL HAEMORRHAGE (ICH): A QUICK GUIDE Overview 10% of strokes is caused by ICH. Main Causes: Less than 40 years old: vascular malformations and illicit drug use.

UPDATE ON STROKE IN OLDER PEOPLE: CLINICAL CASES IN EVERYDAY PRACTICE

UPDATE ON STROKE IN OLDER PEOPLE: CLINICAL CASES IN EVERYDAY PRACTICE Joseph SK Kwan Clinical Associate Professor, HKU Honorary Consultant, Queen Mary Hospital & Grantham Hospital CASE: 82 YEAR OLD LADY

Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar

Anticoagulants and Head Injuries Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar Common Anticoagulants and Indications Coumadin (warfarin) indicated for

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS 11-8-18 Outline 1. Background 2. Anatomy of patent foramen ovale (PFO) 3. Relationship between PFO and

Case Report Isolated Central Sulcus Hemorrhage: A Rare Presentation Most Frequently Associated with Cerebral Amyloid Angiopathy

Case Reports in Radiology Volume 2012, Article ID 574849, 5 pages doi:10.1155/2012/574849 Case Report Isolated Central Sulcus Hemorrhage: A Rare Presentation Most Frequently Associated with Cerebral Amyloid

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

ACUTE ISCHEMIC STROKE Current Treatment Approaches for Acute Ischemic Stroke EARLY MANAGEMENT OF ACUTE ISCHEMIC STROKE Rapid identification of a stroke Immediate EMS transport to nearest stroke center

Amyloid and the Vessels. David Weisman, M.D.

Amyloid and the Vessels David Weisman, M.D. CMA I conduct Alzheimer/amyloid clinical research in conjunction with: Toyoma, ADRC, Genentech, Eisai, Envivo, Accera, Elan, Merck. Previously served on speaker

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available

Investigators meeting. Thursday 7 June 2012

Investigators meeting Thursday 7 June 2012 Future plans Substudies Transient neurological episodes Genetics Biomarkers Retina changes Cognitive follow-up study Thrombolysis ICH Transient focal neurological

MBs present as homogeneous round lesions with signalintensity

ORIGINAL RESEARCH Y. Sueda H. Naka T. Ohtsuki T. Kono S. Aoki T. Ohshita E. Nomura S. Wakabayashi T. Kohriyama M. Matsumoto Positional Relationship between Recurrent Intracerebral Hemorrhage/Lacunar Infarction

Stroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine

Stroke - Intracranial hemorrhage Dr. Amitesh Aggarwal Associate Professor Department of Medicine Etiology and pathogenesis ICH accounts for ~10% of all strokes 30 day mortality - 35 45% Incidence rates

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist Pharmacy Grand Rounds 26 July 2016 2015 MFMER slide-1 Learning

Role of recombinant tissue plasminogen activator in the updated stroke approach

Role of recombinant tissue plasminogen activator in the updated stroke approach Joshua Z. Willey, MD, MS Assistant Professor of Neurology Division of Stroke, Columbia University October 2015 jzw2@columbia.edu

Antithrombotics in Stroke management

Antithrombotics in Stroke management Faculty: Robert Beveridge Relationships with commercial interests: Grants/Research Support: N/A Speakers Bureau/Honoraria: Astra Zeneca, Bayer, Boerhinger Ingelheim,

Cerebrovascular diseases-2

Cerebrovascular diseases-2 Primary angiitis of CNS - Other causes of infarction i. Hypercoagulable states ii. Drug-abuse such as amphetamine, heroin and cocain Note - The venous side of the circulation

Intracerebral Hemorrhage

Review of Primary Intracerebral Hemorrhage Réza Behrouz, DO Assistant Professor of Neurology University of South Florida College of Medicine STROKE 85% ISCHEMIC 15% HEMORRHAGIC HEMORRHAGIC STROKE 1/3 Subarachnoid

TIA: Updates and Management 2008

TIA: Updates and Management 2008 S. Andrew Josephson, MD Department of Neurology, Neurovascular Division University of California San Francisco Commonly Held TIA Misconceptions TIA is easy to diagnose

The HEMORR 2 HAGES, ATRIA and the HAS-BLED bleeding risk prediction scores in anticoagulated atrial fibrillation patients : The AMADEUS study

The HEMORR 2 HAGES, ATRIA and the HAS-BLED bleeding risk prediction scores in anticoagulated atrial fibrillation patients : The AMADEUS study Apostolakis S 1, Lane DA 1, Buller H 2, Lip GY 1 1 University

10 May Disclosure. + Outline. Case-based approach to nontraumatic intracranial hemorrhage. Kathleen R. Fink, MD University of Washington

Kathleen R. Fink, MD University of Washington 5 th Nordic Emergency Radiology Course May 21, 2015 Disclosure My spouse receives research salary support from: Bracco BayerHealthcare Guerbet Outline Case-based

MODULE 1: Stroke Prevention in Atrial Fibrillation Benjamin Bell, MD, FRCPC

MODULE 1: Stroke Prevention in Atrial Fibrillation Benjamin Bell, MD, FRCPC Specialty: General Internal Medicine Lecturer, Department of Medicine University of Toronto Staff Physician, General Internal

True cryptogenic stroke

True cryptogenic stroke Arne Lindgren, MD, PhD Dept of Clinical Sciences Lund, Neurology, Lund University Dept of Neurology and Rehabilitation Medicine Skåne University Hospital Lund, Sweden Disclosures

A Patient Unsuitable for VKA Treatment

Will Apixaban change practice in atrial fibrillation? A Patient Unsuitable for VKA Treatment Professor Yoseph Rozenman The E. Wolfson Medical Center Jerusalem June 2013 Disclosures I have the following

An Introduction to Imaging the Brain. Dr Amy Davis

An Introduction to Imaging the Brain Dr Amy Davis Common reasons for imaging: Clinical scenarios: - Trauma (NICE guidelines) - Stroke - Tumours - Seizure - Neurological degeneration memory, motor dysfunction,

Acute and chronic treatments

21st Annual Meeting of the Swiss Stroke Society Lausanne, 11 January 2018 Vasculitis and stroke : Acute and chronic treatments Pr Mathieu ZUBER Service de Neurologie et NeuroVasculaire Groupe Hospitalier

Case 9511 Hypertensive microangiopathy

Case 9511 Hypertensive microangiopathy Schepers S, Barthels C Section: Neuroradiology Published: 2011, Nov. 3 Patient: 67 year(s), male Authors' Institution Department of Radiology, Jessa ziekenhuis campus

Thrombolytic therapy should be the first line treatment in acute ishchemic stroke. We are against it!!

Thrombolytic therapy should be the first line treatment in acute ishchemic stroke We are against it!! 85% of strokes are ischaemic, and related to blockage of an artery by a blood clot, so potential treatments

The three main subtypes of stroke

Neurology 55 Spontaneous intracerebral haemorrhage in the elderly Spontaneous Intracerebral Haemorrhage (ICH) is defined as bleeding into the brain parenchyma without accompanying trauma. This condition

Atrial Fibrillation. Alan Bell, MD, CCFP. Staff Physician, Humber River Regional Hospital. University of Toronto

Pearls in Thrombosis 1 Atrial Fibrillation Alan Bell, MD, CCFP Staff Physician, Humber River Regional Hospital Assistant tprofessor, Department tof Family and Community Mdii Medicine University of Toronto

Magnetic resonance imaging (MRI) has the potential to

Frequency and Location of Microbleeds in Patients With Primary Intracerebral Hemorrhage Gudrun Roob, MD; Anita Lechner, MD; Reinhold Schmidt, MD; Erich Flooh, MSc; Hans-Peter Hartung, MD; Franz Fazekas,

Cerebrovascular Disease

Neuropathology lecture series Cerebrovascular Disease Physiology of cerebral blood flow Brain makes up only 2% of body weight Percentage of cardiac output: 15-20% Percentage of O 2 consumption (resting):

Manuel Castella MD PhD Hospital Clínic, University of

Manuel Castella MD PhD Hospital Clínic, University of Barcelona mcaste@clinic.ub.es @mcastellamd www.escardio.org/guidelines European Heart Journal - doi:10.1093/eurheartj/ehw210 Providing integrated care

Life after ARUBA: Management of Unruptured Brain Arteriovenous Malformations (AVMs)

Life after ARUBA: Management of Unruptured Brain Arteriovenous Malformations (AVMs) Eric L. Zager, MD University of Pennsylvania Department of Neurosurgery No Disclosures Brain AVMs Incidence ~1 in 100,000

Michael Horowitz, MD Pittsburgh, PA

Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion

Stroke and Headache Headache and Stroke

Stroke and Headache Headache and Stroke Hans-Christoph Diener Senior Professor of Clinical Neurosciences University Duisburg-Essen Tobias Kurth Institute of Public Health Charité Universitätsmedizin Berlin

11/1/2018. Disclosure. Imaging in Acute Ischemic Stroke 2018 Neuro Symposium. Is NCCT good enough? Keystone Heart Consultant, Stock Options

Disclosure Imaging in Acute Ischemic Stroke 2018 Neuro Symposium Keystone Heart Consultant, Stock Options Kevin Abrams, M.D. Chief of Radiology Medical Director of Neuroradiology Baptist Hospital, Miami,

Neurosurgical Management of Stroke

Overview Hemorrhagic Stroke Ischemic Stroke Aneurysmal Subarachnoid hemorrhage Neurosurgical Management of Stroke Jesse Liu, MD Instructor, Neurological Surgery Initial management In hospital management

Stroke imaging. Why image stroke patients? Stroke. Treatment of infarct. Methods for infarct diagnosis. Treatment of infarct.

Stroke imaging Stroke Infarct: -Arterial thrombosis/embolus -Hypoxic/ischemic -Venous thrombosis Non-traumatic hemorrhage: -Intracerebral -Subarachnoid Johan Wikström MD PhD Associate Professor of Radiology

PRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans

PRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans Inclusion Criteria Clinical syndrome Patients must have clinical evidence

Original Research Article

MAGNETIC RESONANCE IMAGING IN MIDDLE CEREBRAL ARTERY INFARCT AND ITS CORRELATION WITH FUNCTIONAL RECOVERY Neethu Tressa Jose 1, Rajan Padinharoot 2, Vadakooth Raman Rajendran 3, Geetha Panarkandy 4 1Junior

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES ALBERTO MAUD, MD ASSOCIATE PROFESSOR TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER EL PASO PAUL L. FOSTER SCHOOL OF MEDICINE 18TH ANNUAL RIO GRANDE TRAUMA 2017

Definition พ.ญ.ส ธ ดา เย นจ นทร. Epidemiology. Definition 5/25/2016. Seizures after stroke Can we predict? Poststroke seizure

Seizures after stroke Can we predict? พ.ญ.ส ธ ดา เย นจ นทร PMK Epilepsy Annual Meeting 2016 Definition Poststroke seizure : single or multiple convulsive episode(s) after stroke and thought to be related

Management of Intracerebral Haemorrhage

Management of Intracerebral Haemorrhage It s the worst type of stroke. Least treatable form of stroke Evidence-base limited most Overall mortality 35-50% Half of these would die within first 24 hours

CEREBRO VASCULAR ACCIDENTS

CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA

MRI Imaging of GP Medicare Eligible Conditions

MRI Imaging of GP Medicare Eligible Conditions By Dr. Andrew Stuart Radiologist Sydney Adventist Hospital 0562/SAH/1112/SAH Learning Objectives Indications for GP referred Medicare eligible MRI scans MRI

Stroke/TIA. Tom Bedwell

Stroke/TIA Tom Bedwell tab1g11@soton.ac.uk The Plan Definitions Anatomy Recap Aetiology Pathology Syndromes Brocas / Wernickes Investigations Management Prevention & Prognosis TIAs Key Definitions Transient

Disclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT

Disclosures An Update on TIA and Minor Stroke Dr. Johnston is principal investigator for the POINT trial, sponsored by the NIH but with drug and placebo contributed by Sanofi-Aventis. S. Claiborne Johnston,

Small vessel disease and post stroke cognitive impairment

Small vessel disease and post stroke cognitive impairment Dr Fergus Doubal Stroke Association Clinical Senior Lecturer Consultant Stroke Physician and Geriatrician Royal Infirmary of Edinburgh Outline

Silent Cerebral Strokes: Clinical Outcomes and Management

Silent Cerebral Strokes: Clinical Outcomes and Management Nagaendran Kandiah Senior Consultant Neurologist, National Neuroscience Institute, Singapore Clinician Scientist, National Medical Research Council,

TRANSIENT ISCHEMIC ATTACK (TIA)

TRANSIENT ISCHEMIC ATTACK (TIA) AND MINOR STROKE Dr. Leanne K. Casaubon, MD MSc FRCPC Associate Professor, University of Toronto Director, TIA and Minor Stroke (TAMS) Unit University Health Network - Toronto

. 8. Pharmacological treatment in acute stroke 8.3 Antiplatelet and anticoagulant treatment in stroke due to arterial dissection

. 8. Pharmacological treatment in acute stroke 8.3 Antiplatelet and anticoagulant treatment in stroke due to arterial dissection Reference Evidence Tables PHARM4 What is the safety and efficacy of anticoagulants

C. Douglas Phillips, MD FACR Director of Head and Neck Imaging Weill Cornell Medical College NewYork-Presbyterian Hospital

C. Douglas Phillips, MD FACR Director of Head and Neck Imaging Weill Cornell Medical College NewYork-Presbyterian Hospital I have no financial disclosures Understand range of pathology that may present

Stroke Update. Claire J. Creutzfeldt, MD January 12, 2018

Stroke Update Claire J. Creutzfeldt, MD January 12, 2018 Disclosures None relevant to this presentation I receive funding from the NINDS What s new in stroke? A new model for cardioembolic stroke: atrial

NOACs Update PD Dr. Jan Steffel Leitender Arzt, Klinik für Kardiologie Co-Leiter Rhythmologie Universitätsspital Zürich

NOACs Update 2016 PD Dr. Jan Steffel Leitender Arzt, Klinik für Kardiologie Co-Leiter Rhythmologie Universitätsspital Zürich Conflict of Interest Statement o o o o Consulting: Amgen, Astra Zeneca, AtriCure,

Outlook for intracerebral haemorrhage after a MISTIE spell

Outlook for intracerebral haemorrhage after a MISTIE spell David J Werring PhD FRCP Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, National Hospital

Secondary Preven-on of Thromboembolic Stroke: Clinical Data and Recommenda-ons from the ESC Atrial Fibrilla-on Guideline Update 2012

Secondary Preven-on of Thromboembolic Stroke: Clinical Data and Recommenda-ons from the ESC Atrial Fibrilla-on Guideline Update 2012 Professor Dan Atar Head, Dept. of Cardiology Councillor of the ESC,

Indications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute

Indications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute Disclosures Research Support/P.I. Employee Leo Pharma

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives

Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE

Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE ESUS Progression of haematoma Anticoagulation Large ICH

La gestione dell ictus ischemico o emorragico nel paziente sotto NAO

La gestione dell ictus ischemico o emorragico nel paziente sotto NAO Antonio Carolei e Cindy Tiseo Clinica Neurologica e Stroke Unit Avezzano - Sulmona Università degli Studi dell Aquila Abano Terme, 10

Venous thrombosis in unusual sites

Venous thrombosis in unusual sites Walter Ageno Department of Medicine and Surgery University of Insubria Varese Italy Disclosures Employment Research support Scientific advisory board Consultancy Speakers

Treatment of Acute Hemorrhagic Stroke 5th QSVS Neurovascular Conference Dar Dowlatshahi MD PhD FRCPC Sept 14, 2012

Treatment of Acute Hemorrhagic Stroke 5th QSVS Neurovascular Conference Dar Dowlatshahi MD PhD FRCPC Sept 14, 2012 Disclosure of potential conflicts of interest Quebec Society of Vascular Sciences presents